Clinical Trials

Washington University neurologists are leading groundbreaking clinical trials aimed at improving the neurological health of people throughout the world.

By participating in a clinical trial, our patients are shaping the future of medicine. Clinical trials allow researchers to study new treatment options, drugs or combinations of treatments to determine if they can be integrated into a standard practice of care. A list of active clinical trials is provided below.

Genetics of Neurologic and Neuromuscular Disorders

Culture and analysis of dermal fibroblasts from patients with neurologic or neuromuscular disorders

Neurologic and Neuromuscular Biorepository – Cerebrospinal Fluid

Evaluation of Biomarkers in Blood of patients with Neuromuscular Diseases

A Phase 3, Multi-National, Double-Blind, Randomized, Placebo-Controlled, Stratified, Parallel Group, Study to Evaluate the Safety, Tolerability and Efficacy of Tirasemtiv in Patients with Amyotrophic Lateral Sclerosis (ALS)

A Phase 1, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BIIB067 Administered to Adult Subjects with Amyotrophic Lateral Sclerosis

Genomic Translation for ALS Clinical Care (GTAC)

Cross-Sectional ALS Biofluid Biomarker (CABB) Study

Methodology Study of Novel Electrophysiological, Physical, and Imaging Outcome Measures to Assess the Progression of Amyotrophic Lateral Sclerosis

Answer ALS: Individualized Initiative for ALS Discovery